AB1371 Severity of incident vertebral fracture and future fracture risk: A 3-year prospective study

2013 ◽  
Vol 71 (Suppl 3) ◽  
pp. 716.6-716 ◽  
Author(s):  
O. Bruyere ◽  
C. Roux ◽  
D. Nicolet ◽  
J. Fechtenbaum ◽  
R. Deroisy ◽  
...  
2018 ◽  
Vol 33 (7) ◽  
pp. 1233-1241 ◽  
Author(s):  
Mayke J van Dort ◽  
Piet Geusens ◽  
Johanna HM Driessen ◽  
Elisabeth APM Romme ◽  
Frank WJM Smeenk ◽  
...  

2002 ◽  
Vol 17 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Somnath Sarkar ◽  
Bruce H. Mitlak ◽  
Mayme Wong ◽  
John L. Stock ◽  
Dennis M. Black ◽  
...  

2002 ◽  
Vol 57 (7) ◽  
pp. 446-448
Author(s):  
Somnath Sarkar ◽  
Bruce H. Mitlak ◽  
Mayme Wong ◽  
John L. Stock ◽  
Dennis M. Black ◽  
...  

Author(s):  
Fjorda Koromani ◽  
Samuel Ghatan ◽  
Mandy van Hoek ◽  
M. Carola Zillikens ◽  
Edwin H. G. Oei ◽  
...  

Abstract Purpose of Review The purpose of this review is to summarize the recently published evidence concerning vertebral fracture risk in individuals with diabetes mellitus. Recent Findings Vertebral fracture risk is increased in individuals with T2DM. The presence of vertebral fractures in T2DM is associated with increased non-vertebral fracture risk and mortality. TBS could be helpful to estimate vertebral fracture risk in individuals with T2DM. An increased amount of bone marrow fat has been implicated in bone fragility in T2DM. Results from two recent studies show that both teriparatide and denosumab are effective in reducing vertebral fracture risk also in individuals with T2DM. Summary Individuals with T2DM could benefit from systematic screening in the clinic for presence of vertebral fractures.


1996 ◽  
Vol 6 (S1) ◽  
pp. 132-132
Author(s):  
K. E. Ensrud ◽  
R. C. Lipschutz ◽  
J. A. Cauley ◽  
M. C. Nevitt ◽  
S. R. Cummings ◽  
...  

2004 ◽  
Vol 22 (5) ◽  
pp. 462-468 ◽  
Author(s):  
Kazuhiro Kushida ◽  
Masataka Shiraki ◽  
Toshitaka Nakamura ◽  
Hideaki Kishimoto ◽  
Hirotoshi Morii ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document